Nadim Ahmed

Nadim Ahmed has a strong background in the pharmaceutical industry with extensive experience in oncology and hematology. Nadim is currently serving as the President and CEO of Cullinan Oncology since October 2021. Prior to this role, Nadim worked as the EVP and President of Hematology at Bristol Myers Squibb from November 2019 to January 2021. Nadim also held several leadership positions at Celgene Corporation, including President of Global Hematology & Oncology from August 2017 to November 2019. Before joining Celgene, Nadim worked at GSK for over 18 years, holding various roles in clinical development, medical affairs, and global and US marketing. Overall, Nadim Ahmed has a diverse range of experience in the pharmaceutical industry, particularly in the field of oncology and hematology.

Nadim Ahmed has a Master of Science (MS) degree in Information Technology from Loughborough University. Prior to that, they obtained a Bachelor of Science (BS) degree in Pharmacology from UCL.